Literature DB >> 11747459

Kinetic and mechanistic studies of penicillin-binding protein 2x from Streptococcus pneumoniae.

B Thomas1, Y Wang, R L Stein.   

Abstract

High molecular weight penicillin-binding proteins (PBPs) are bifunctional enzymes that build bacterial cell walls from the glycopeptide lipid II [GlcNAc-MurNAc(L-Ala-gamma-D-Glu-L-Lys-D-Ala-D-Ala)-pyrophosphate-undecaprenol] by a process involving disaccharide polymerization and peptide cross-linking. The latter reaction involves acyl-transfer chemistry in which the penultimate (D)Ala first acylates the active-site serine, with release of the terminal (D)Ala, and is then transferred to the epsilon-amine of a Lys on a neighboring pentapeptide chain. These enzymes also catalyze hydrolysis of specific thioester substrates and acylation by beta-lactam antibiotics. In this paper, we explore these latter two reactions and report mechanistic experiments on the reaction of Streptococcus pneumoniae PBP 2x with N-benzoyl-(D)Ala-thioacetic acid [Bz-(D)Ala-(S)Gly] and penicillin G. For these experiments, we used PBP 2x, a soluble form of PBP 2x in which the transmembrane domain was deleted. The following results are significant: (1) pH dependencies for acylation of PBP 2x by penicillin G and Bz-(D)Ala-(S)Gly are identical, suggesting that the same ionizable residues are involved in both reactions and that these residues play the same catalytic role in the two processes. On the basis of these results, we propose a mechanistic model that is also consistent with recently published structural data [Gordon, E., et al. (2000) J. Mol. Biol. 299, 477-485]. (2) Pre-steady-state experiments for the PBP 2x-catalyzed hydrolysis of Bz-(D)Ala-(S)Gly at pH 6.5 indicate that k(c) is principally rate-limited by acylation with some contribution from deacylation. The contribution of these steps to rate limitation is pH-dependent, with acylation entirely rate-limiting at pH values less than 5.5 and deacylation principally rate-limiting above pH 8.5. (3) Results of solvent isotope effect and proton inventory experiments for acylation suggest a complex process that is at least partially rate-limited by chemistry with some involvement of changes in solvation and/or enzyme conformation. (4) Analysis of activation parameters suggests that during the acylation of PBP 2x by penicillin G the inherent chemical stability of penicillin's amide bond, as manifested in the enthalpy of activation, is offset by a favorable entropy term that reflects penicillin's rotationally constrained bicyclic system, which presumably allows a less energetically demanding entry into the transition state for acylation.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11747459     DOI: 10.1021/bi011368r

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  4 in total

1.  A large displacement of the SXN motif of Cys115-modified penicillin-binding protein 5 from Escherichia coli.

Authors:  George Nicola; Alena Fedarovich; Robert A Nicholas; Christopher Davies
Journal:  Biochem J       Date:  2005-11-15       Impact factor: 3.857

2.  Protonation states of active-site lysines of penicillin-binding protein 6 from Escherichia coli and the mechanistic implications.

Authors:  Malika Kumarasiri; Weilie Zhang; Qicun Shi; Jed F Fisher; Shahriar Mobashery
Journal:  Proteins       Date:  2014-02-06

3.  Discovery of Pyrrolidine-2,3-diones as Novel Inhibitors of P. aeruginosa PBP3.

Authors:  Arancha López-Pérez; Stefan Freischem; Immanuel Grimm; Oliver Weiergräber; Andrew J Dingley; María Pascual López-Alberca; Herbert Waldmann; Waldemar Vollmer; Kamal Kumar; Cuong Vuong
Journal:  Antibiotics (Basel)       Date:  2021-05-04

4.  High-Throughput Crystallography Reveals Boron-Containing Inhibitors of a Penicillin-Binding Protein with Di- and Tricovalent Binding Modes.

Authors:  Hector Newman; Alen Krajnc; Dom Bellini; Charles J Eyermann; Grant A Boyle; Neil G Paterson; Katherine E McAuley; Robert Lesniak; Mukesh Gangar; Frank von Delft; Jürgen Brem; Kelly Chibale; Christopher J Schofield; Christopher G Dowson
Journal:  J Med Chem       Date:  2021-07-31       Impact factor: 8.039

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.